Adamis Pharmaceuticals Corp (ADMP) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 199 transactions totaling $2.3M, demonstrating a bearish sentiment with -$1.9M in net insider flow. The most recent transaction on May 25, 2023 involved a transaction of 177,194 shares valued at $0.
No significant insider buying has been recorded for ADMP in the recent period.
No significant insider selling has been recorded for ADMP in the recent period.
Based on recent SEC filings, insider sentiment for ADMP is bearish with an Insider Alignment Score of 8/100 and a net flow of -$1.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Adamis Pharmaceuticals Corp (ADMP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading ADMP stock, having executed 199 transactions in the past 90 days. The most active insider is Holdings (fze) Eses (Executive), who has made 19 transactions totaling $2.9M.
Get notified when executives and directors at ADMP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 25, 2023 | Versi Jannine | Executive | Award | 177,194 | $N/A | $0 | |
| May 25, 2023 | J. Desai Meera | Executive | Award | 3,138 | $N/A | $0 | |
| May 25, 2023 | Versi Ebrahim | Executive | Award | 8,745 | $N/A | $0 | |
| May 25, 2023 | Versi Ebrahim | Executive | Award | 177,194 | $N/A | $0 | |
| May 25, 2022 | J. Carlo Dennis Phd | Executive | Option Exercise | 250,000 | $N/A | $0 | |
| Mar 18, 2022 | C. Benedicto David | Executive | Sale | 3,603 | $0.61 | $2.2K | |
| Mar 18, 2022 | J. Carlo Dennis Phd | Executive | Sale | 10,490 | $0.60 | $6.3K | |
| Mar 18, 2022 | J. Marguglio David | Executive | Sale | 11,859 | $0.60 | $7.1K | |
| Mar 18, 2022 | B. Moss Ronald | Executive | Sale | 8,199 | $0.60 | $4.9K | |
| Dec 9, 2021 | J. Marguglio David | Executive | Gift | 13,000 | $N/A | $0 | |
| Dec 1, 2021 | J. Carlo Dennis Phd | Executive | Sale | 47,870 | $0.79 | $37.8K | |
| Dec 1, 2021 | J. Marguglio David | Executive | Sale | 50,757 | $0.79 | $40.1K | |
| Dec 1, 2021 | B. Moss Ronald | Executive | Sale | 35,553 | $0.79 | $28.1K | |
| Dec 1, 2021 | C. Benedicto David | Executive | Sale | 13,554 | $0.79 | $10.7K | |
| Feb 21, 2021 | J. Carlo Dennis Phd | Executive | Option Exercise | 27,822 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 27 | $2.5M | 50.9% |
Sale(S) | 107 | $2.1M | 43.0% |
Purchase(P) | 8 | $188.8K | 3.8% |
Gift(G) | 42 | $108.0K | 2.2% |
Exercise(M) | 15 | $0 | 0.0% |
Insider selling pressure at Adamis Pharmaceuticals Corp has increased, with 19 insiders executing 199 transactions across all time. Total sales of $2.1M significantly outpace purchases of $188.8K, resulting in a net outflow of $1.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.